735 related articles for article (PubMed ID: 12229962)
1. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
[TBL] [Abstract][Full Text] [Related]
2. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
3. Serum progastrin and its products, gastric acid secretion and serum pepsinogen I in gastric cancer.
Konturek SJ; Konturek PC; Bielanski W; Karczewska E; Zuchowicz M; Hartwich A; Rehfeld JF; Goetze JP; Hahn EG
Digestion; 2003; 68(4):169-77. PubMed ID: 14671424
[TBL] [Abstract][Full Text] [Related]
4. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients.
Parente F; Imbesi V; Maconi G; Cucino C; Sangaletti O; Vago L; Bianchi Porro G
Am J Gastroenterol; 1998 Jul; 93(7):1073-9. PubMed ID: 9672333
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori-gastrin link in MALT lymphoma.
Konturek PC; Konturek SJ; Starzyska T; Marlicz K; Bielanski W; Pierzchalski P; Karczewska E; Hartwich A; Rembiasz K; Lawniczak M; Ziemniak W; Hahn EC
Aliment Pharmacol Ther; 2000 Oct; 14(10):1311-8. PubMed ID: 11012476
[TBL] [Abstract][Full Text] [Related]
6. Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients.
Konturek PC; Konturek SJ; Bielanski W; Kania J; Zuchowicz M; Hartwich A; Rehfeld JF; Hahn EG
Dig Dis Sci; 2003 Oct; 48(10):2005-17. PubMed ID: 14627349
[TBL] [Abstract][Full Text] [Related]
7. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
9. Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer.
Yamada S; Kato S; Matsuhisa T; Makonkawkeyoon L; Yoshida M; Chakrabandhu T; Lertprasertsuk N; Suttharat P; Chakrabandhu B; Nishiumi S; Chongraksut W; Azuma T
World J Gastroenterol; 2013 May; 19(19):2941-9. PubMed ID: 23704827
[TBL] [Abstract][Full Text] [Related]
10. CagA seropositivity associated with development of gastric cancer in a Japanese population.
Shimoyama T; Fukuda S; Tanaka M; Mikami T; Munakata A; Crabtree JE
J Clin Pathol; 1998 Mar; 51(3):225-8. PubMed ID: 9659265
[TBL] [Abstract][Full Text] [Related]
11. IgG2 response and low IgG titre specific to Helicobacter pylori CagA as serological markers for gastric cancer.
de la Cruz-Herrera CF; Flores-Luna L; Gutierrez-Xicotencatl L; Chihu-Amparan L; Sánchez-Aleman MA; Lazcano-Ponce E; Torres J; Ayala G
J Med Microbiol; 2013 Apr; 62(Pt 4):591-598. PubMed ID: 23288428
[TBL] [Abstract][Full Text] [Related]
12. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of
Fernandez-Botran R; Wellmann IA; Une C; Méndez-Chacón E; Hernández de Rodas E; Bhandari B; Villagrán de Tercero CI
Am J Trop Med Hyg; 2020 Jul; 103(1):260-265. PubMed ID: 32314688
[TBL] [Abstract][Full Text] [Related]
14. 'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection.
Di Mario F; Moussa AM; Caruana P; Merli R; Cavallaro LG; Cavestro GM; Dal Bò N; Iori V; Pilotto A; Leandro G; Franzè A; Rugge M
Scand J Gastroenterol; 2003 Dec; 38(12):1223-7. PubMed ID: 14750641
[TBL] [Abstract][Full Text] [Related]
15. Association of Helicobacter pylori cagA Gene with Gastric Cancer and Peptic Ulcer in Saudi Patients.
Saber T; Ghonaim MM; Yousef AR; Khalifa A; Al Qurashi H; Shaqhan M; Samaha M
J Microbiol Biotechnol; 2015 Jul; 25(7):1146-53. PubMed ID: 25791852
[TBL] [Abstract][Full Text] [Related]
16. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.
Yamaoka Y; Kodama T; Kashima K; Graham DY
J Clin Pathol; 1999 Mar; 52(3):215-8. PubMed ID: 10450182
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.
Beales IL; Crabtree JE; Scunes D; Covacci A; Calam J
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):645-9. PubMed ID: 8853252
[TBL] [Abstract][Full Text] [Related]
18. Interactions between pork consumption, CagA status and IL-1B-31 genotypes in gastric cancer.
Wang XQ; Terry PD; Cheng L; Yan H; Wang JS; Wu WA; Hu SK
World J Gastroenterol; 2014 Jul; 20(25):8151-7. PubMed ID: 25009387
[TBL] [Abstract][Full Text] [Related]
19. Cancerogenesis in Helicobacter pylori infected stomach--role of growth factors, apoptosis and cyclooxygenases.
Konturek PC; Konturek SJ; Pierzchalski P; Bielański W; Duda A; Marlicz K; Starzyńska T; Hahn EG
Med Sci Monit; 2001; 7(5):1092-107. PubMed ID: 11535962
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt.
Said Essa A; Alaa Eldeen Nouh M; Mohammed Ghaniam N; Graham DY; Said Sabry H
Scand J Infect Dis; 2008; 40(9):730-3. PubMed ID: 19086246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
